ロード中...
Protection against TB with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8(+) T cells
Considerable effort has been directed to develop Mycobacterium tuberculosis (Mtb) vaccines to boost BCG or for those who cannot be immunized with BCG. We hypothesized that CD4(+) and CD8(+) T cell responses with a heterologous prime/boost vaccine approach could induce long-lived vaccine efficacy aga...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3791622/ https://ncbi.nlm.nih.gov/pubmed/23904160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1301161 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|